ClinicalTrials.Veeva

Menu
V

Vall d'Hebron Barcelona Hospital Campus | Vall d'Hebron Hospital Universitario - Cardiology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BX004-A

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler (earlyGRAFD)

This is a multicentre, open-label, randomized controlled trial. A total of 340 singleton pregnancies with an EFW ≤10th percentile between 26+0 and 31...

Not yet enrolling
Fetal Growth Retardation
Preeclampsia
Diagnostic Test: soluble fms-like tyrosine kinase to placental growth factor ratio (sFlt-1/PlGF)

This is a Phase 1b/2a study with the primary objective to determine if BX004-A is safe and tolerable. Exploratory objectives include whether BX004-A...

Active, not recruiting
Cystic Fibrosis
Chronic Pseudomonas Aeruginosa Infection
Drug: BX004-A
Drug: Placebo

The main objective of this study is to evaluate the efficacy and safety of ABO-102 for the treatment of MPS IIIA.

Active, not recruiting
Sanfilippo A
MPS IIIA
Biological: ABO-102
Drug: Adjuvant Immunosuppression (IS) Therapy

Trial sponsors

V
B
Ultragenyx logo
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems